CSF level of β-amyloid peptide predicts mortality in Alzheimer’s disease

被引：0
|
作者：
Adla Boumenir
Emmanuel Cognat
Severine Sabia
Claire Hourregue
Matthieu Lilamand
Aline Dugravot
Elodie Bouaziz-Amar
Jean-Louis Laplanche
Jacques Hugon
Archana Singh-Manoux
Claire Paquet
Julien Dumurgier
机构：
[1] Université Paris Diderot,Cognitive Neurology Center, Saint Louis
[2] Sorbonne Paris Cité, Lariboisiere
[3] Paris Descartes University, Fernand Widal Hospital, AP
[4] AP-HP,HP
[5] Sorbonne Paris Cité,INSERM UMR1153, Centre of Research in Epidemiology and StatisticS
[6] Saint Louis - Lariboisiere - Fernand Widal Hospital,Department of biochemistry
[7] AP-HP,Department of Epidemiology and Public Health
[8] University College London,undefined
来源：
Alzheimer's Research & Therapy | / 11卷
关键词：
Alzheimer’s disease; CSF biomarkers; β-amyloid peptide; Mortality;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Intracellular biology of Alzheimer's disease amyloid beta peptide
    Hartmann, T
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 1999, 249 (06) : 291 - 298
  • [42] Why is the amyloid beta peptide of Alzheimer's disease neurotoxic?
    Rauk, Arvi
    DALTON TRANSACTIONS, 2008, (10) : 1273 - 1282
  • [43] Amyloid Peptide Scaffolds Coordinate with Alzheimer's Disease Drugs
    Jonnalagadda, Sai Vamshi R.
    Gerace, Andrew James
    Thai, Kathleen
    Johnson, Jonathan
    Tsimenidis, Kostas
    Jakubowski, Joseph M.
    Shen, Christina
    Henderson, Kendal J.
    Tamamis, Phanourios
    Gkikas, Manos
    JOURNAL OF PHYSICAL CHEMISTRY B, 2020, 124 (03): : 487 - 503
  • [44] Arginine and Disordered Amyloid-β Peptide Structures: Molecular Level Insights into the Toxicity in Alzheimer's Disease
    Coskuner, Orkid
    Wise-Scira, Olivia
    ACS CHEMICAL NEUROSCIENCE, 2013, 4 (12): : 1549 - 1558
  • [45] The Mechanism Underlying Amyloid Polymorphism is Opened for Alzheimer's Disease Amyloid-β Peptide
    Selivanova, Olga M.
    Surin, Alexey K.
    Marchenkov, Victor V.
    Dzhus, Ulyana F.
    Grigorashvili, Elizaveta I.
    Suvorina, Mariya Yu.
    Glyakina, Anna V.
    Dovidchenko, Nikita V.
    Galzitskaya, Oxana V.
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 54 (02) : 821 - 830
  • [46] Dissociation of amyloid biomarkers in PET and CSF in Alzheimer's disease: a case report
    Schroeter, Matthias L.
    Tiepolt, Solveig
    Marschhauser, Anke
    Thoene-Otto, Angelika
    Hoffmann, Karl-Titus
    Barthel, Henryk
    Obrig, Hellmuth
    Sabri, Osama
    BMC NEUROLOGY, 2015, 15
  • [47] CSF β-amyloid and white matter damage: a new perspective on Alzheimer's disease
    Pietroboni, Anna M.
    Scarioni, Marta
    Carandini, Tiziana
    Basilico, Paola
    Cadioli, Marcello
    Giulietti, Giovanni
    Arighi, Andrea
    Caprioli, Michela
    Serra, Laura
    Sina, Clara
    Fenoglio, Chiara
    Ghezzi, Laura
    Fumagalli, Giorgio G.
    De Riz, Milena A.
    Calvi, Alberto
    Triulzi, Fabio
    Bozzali, Marco
    Scarpini, Elio
    Galimberti, Daniela
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (04): : 352 - 357
  • [48] CSF beta-amyloid, cognition, and APOE genotype in Alzheimer's disease
    Samuels, SC
    Silverman, JM
    Marin, DB
    Peskind, ER
    Younki, SG
    Greenberg, DA
    Schnur, E
    Santoro, J
    Davis, KL
    NEUROLOGY, 1999, 52 (03) : 547 - 551
  • [49] Dissociation of amyloid biomarkers in PET and CSF in Alzheimer’s disease: a case report
    Matthias L. Schroeter
    Solveig Tiepolt
    Anke Marschhauser
    Angelika Thöne-Otto
    Karl-Titus Hoffmann
    Henryk Barthel
    Hellmuth Obrig
    Osama Sabri
    BMC Neurology, 15
  • [50] Erratum to: Different CSF β-amyloid processing in Alzheimer’s and Creutzfeldt–Jakob disease
    Brit Mollenhauer
    Hermann Esselmann
    Sigrun Roeber
    Walter J. Schulz-Schaeffer
    Claudia Trenkwalder
    Mirko Bibl
    Petra Steinacker
    Hans A. Kretzschmar
    Jens Wiltfang
    Markus Otto
    Journal of Neural Transmission , 2011, 118 : 1261 - 1262
12345